BACK

Vivian Xu

Vivian Xu

Associate

New York Office  |  vivian.xu@torreya.com   |   212.257.6026

Vivian Xu, an Associate at Torreya, provides transaction support for companies across different sectors in the healthcare industry.

Before joining Torreya’s team in 2016, Vivian worked as an Investment Analyst for the healthcare investment team at Fosun Group.

Vivian earned a B.A. in international journalism and communication as well as international economics and trade from Beijing Foreign Studies University. She received her M.A. in public administration from Columbia University, with a concentration in finance and energy. Vivian speaks Mandarin and has extensive experience in English-Chinese two-way translation.

Selected Transactions

EA Pharma
License of AJT-240 in hemodialysis in China to
Tasly Pharmaceutical Group Co., Ltd.
Up to $24 million
June 2018
Sandoz
Sale of
ANDA portfolio to
CASI Pharmaceuticals
Undisclosed
January 2018
Sandoz
Sale of OTC
portfolio to
PLD
Undisclosed
December 2017
Sandoz
Sale of
generics portfolio to
FosunPharma
$18 million
August 2017
Essential Pharmaceuticals
Asset sale to
Accord
Undisclosed
July 2017
Durect
License of US rights to Posimir® to
Sandoz
$293 million
May 2017